These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20932171)

  • 21. Potential new clinical therapies for Chagas disease.
    Bustamante JM; Tarleton RL
    Expert Rev Clin Pharmacol; 2014 May; 7(3):317-25. PubMed ID: 24716790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas' disease.
    Jackson Y; Wyssa B; Chappuis F
    J Antimicrob Chemother; 2020 Mar; 75(3):690-696. PubMed ID: 31754690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
    Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
    Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution.
    Fabbro DL; Streiger ML; Arias ED; Bizai ML; del Barco M; Amicone NA
    Rev Soc Bras Med Trop; 2007; 40(1):1-10. PubMed ID: 17486245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.
    Bianchi F; Cucunubá Z; Guhl F; González NL; Freilij H; Nicholls RS; Ramírez JD; Montilla M; Flórez AC; Rosas F; Saavedra V; Silva N
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003465. PubMed ID: 25723465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
    Cabrera E; Murguiondo MG; Arias MG; Arredondo C; Pintos C; Aguirre G; Fernández M; Basmadjián Y; Rosa R; Pacheco JP; Raymondo S; Di Maio R; González M; Cerecetto H
    Eur J Med Chem; 2009 Oct; 44(10):3909-14. PubMed ID: 19446929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Part VI. Antiparasitic treatment for Chagas disease].
    B WA; G IH; L MI; M LJ; V PM; H IN; V AM; P JS; H MT; A IZ
    Rev Chilena Infectol; 2008 Oct; 25(5):384-9, discussion 387. PubMed ID: 18949153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enantiomers of nifurtimox do not exhibit stereoselective anti-Trypanosoma cruzi activity, toxicity, or pharmacokinetic properties.
    Moraes CB; White KL; Braillard S; Perez C; Goo J; Gaspar L; Shackleford DM; Cordeiro-da-Silva A; Thompson RC; Freitas-Junior L; Charman SA; Chatelain E
    Antimicrob Agents Chemother; 2015; 59(6):3645-7. PubMed ID: 25845874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
    Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).
    Castro JA; de Mecca MM; Bartel LC
    Hum Exp Toxicol; 2006 Aug; 25(8):471-9. PubMed ID: 16937919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of nifurtimox for the treatment of chronic Chagas disease].
    Fuentes B R; Maturana A M; de la Cruz M R
    Rev Chilena Infectol; 2012 Feb; 29(1):82-6. PubMed ID: 22552516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognizing and meeting the challenge of Chagas disease in the USA.
    Bowling J; Walter EA
    Expert Rev Anti Infect Ther; 2009 Dec; 7(10):1223-34. PubMed ID: 19968514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the ELISA-F29 test as an early marker of therapeutic efficacy in adults with chronic Chagas disease.
    Fabbro D; Velazquez E; Bizai ML; Denner S; Olivera V; Arias E; Pravia C; Ruiz AM
    Rev Inst Med Trop Sao Paulo; 2013; 55(3):. PubMed ID: 23740013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country.
    Carrilero B; Murcia L; Martínez-Lage L; Segovia M
    Rev Esp Quimioter; 2011 Sep; 24(3):123-6. PubMed ID: 21947093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic Chagas' disease in the mouse. IV. Effect of trypanocidal drugs.
    Laguens RP; Cabeza Meckert P; Chambó JG; Gelpi R
    Medicina (B Aires); 1983; 43(2):126-30. PubMed ID: 6420640
    [No Abstract]   [Full Text] [Related]  

  • 36. Antitrypanosomal agents: treatment or threat?
    Issa VS; Bocchi EA
    Lancet; 2010 Sep; 376(9743):768; author reply 768-9. PubMed ID: 20816538
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease.
    Gallerano RH; Marr JJ; Sosa RR
    Am J Trop Med Hyg; 1990 Aug; 43(2):159-66. PubMed ID: 2117857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term comparative pharmacovigilance of orally transmitted Chagas disease: first report.
    Alarcón de Noya B; Ruiz-Guevara R; Noya O; Castro J; Ossenkopp J; Díaz-Bello Z; Colmenares C; Suárez JA; Noya-Alarcón O; Naranjo L; Gutiérrez H; Quinci G; Torres J
    Expert Rev Anti Infect Ther; 2017 Mar; 15(3):319-325. PubMed ID: 28132566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trypanosoma cruzi: a novel chemical class (nitrobenzofurans) active against infections of mice (Mus musculus).
    Kinnamon KE; Poon BT; Hanson WL; Waits VB
    Exp Parasitol; 1998 Jun; 89(2):251-6. PubMed ID: 9635449
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recommendations for diagnosis, treatment and follow-up of the Trypanosoma cruzi: human immunodeficiency virus co-infection].
    Rev Soc Bras Med Trop; 2006; 39(4):392-415. PubMed ID: 17119760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.